Shuttle Pharmaceuticals Holdings (SHPH) Liabilities and Shareholders Equity (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 122.39% year-over-year to $11.8 million in Q1 2026; TTM through Mar 2026 was $31.3 million, a 177.21% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 317.99% from the prior year.
• Liabilities and Shareholders Equity advanced to $11.8 million in Q1 2026 per SHPH's latest filing, from $10.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $11.8 million in Q1 2026 and bottomed at $673568.0 in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $6.0 million (2023), against an average of $6.5 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 1227.96% in 2022 and sank 90.87% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $8.7 million in 2022, then sank by 31.22% to $6.0 million in 2023, then tumbled by 57.89% to $2.5 million in 2024, then jumped by 317.99% to $10.5 million in 2025, then gained by 12.73% to $11.8 million in 2026.
• Per Business Quant, the three latest SHPH Liabilities and Shareholders Equity figures stand at $11.8 million (Q1 2026), $10.5 million (Q4 2025), and $3.5 million (Q3 2025).